Market Cap: $8.87B
BC
Bruker Corporation
BRKR
NASDAQ (NASDAQ Global Select)USD
Market Cap: $8.87B
Bruker Corporation (Ticker: BRKR) is advancing its presence in the life sciences sector through innovative instruments and strategic financial maneuvers. Recently, the company showcased its latest mas…
Bruker Corporation (Ticker: BRKR) announces its new omnibus universal shelf registration, a strategic move that enhances its capital-raising capabilities. This initiative allows Bruker to issue a vari…
In recent developments, Bruker Corporation (Ticker: BRKR) showcases its commitment to innovation and growth in the healthcare and biotechnology sectors through significant advancements in its diagnost…
Bruker Corporation (Ticker: BRKR) demonstrates a significant advancement in its technology offerings, particularly showcased during the ASM Microbe 2026 conference. At this event, Bruker introduces ne…
Bruker Corporation (Ticker: BRKR) has recently garnered attention due to the commissioning of its advanced BioSpec 18 Tesla preclinical MRI system at the Champalimaud Foundation in Lisbon. This cuttin…
Bruker Positioned for Innovation in Fusion Energy Development The U.S. Department of Energy (DOE) is spearheading a transformative initiative to transition fusion energy from research laboratories to…
Bruker Strengthens Position in MRI Technology with New Supply Agreements Bruker Corporation, through its Bruker Energy & Supercon Technologies (BEST) division, has solidified its role in the healthcar…
Bruker Corporation's Resilience Amid Market Challenges Bruker Corporation reports its third-quarter earnings, showcasing a noteworthy resilience despite experiencing declines in both profit and revenu…
Bruker Gears Up for Key Earnings Announcement: Insights into R&D and Market Position Bruker, a prominent player in the scientific instruments sector, is poised to release its quarterly earnings on Nov…
Bruker Advances in Analytical Solutions Amid Economic Uncertainty Bruker Corporation, a leader in scientific instrumentation, continues to focus on delivering innovative analytical solutions despite a…
Bruker Corporation's Analyst Ratings Reflect Diverse Market Sentiment Bruker Corporation stands at a critical juncture as it navigates a competitive landscape in the scientific instrumentation sector.…
Bruker Inc. Faces Operational Stability Amid Stock Volatility Bruker Inc., a leader in scientific instruments and analytical solutions, currently experiences a complex landscape marked by operational…
Bruker's Operational Stability Amid Stock Price Fluctuations Bruker Inc. continues to demonstrate operational stability, even as its stock experiences significant fluctuations. Despite a recent uptick…
Bruker Faces Market Challenges Amid Convertible Stock Sale Bruker Corporation, a leader in scientific instruments and analytical solutions, experiences a significant decline in its stock price, plumme…
Bruker Faces Market Challenges Amid Convertible Stock Sale Bruker Corporation grapples with significant market pressures following its recent announcement of a $600 million convertible stock sale. The…
Sotera Health’s Strategic Positioning Ahead of Earnings Announcement Sotera Health SHC is gearing up for its quarterly earnings report, scheduled for August 8, 2025, which is anticipated to provide es…
Bruker's Strategic Response to Market Challenges Bruker Corporation faces a pivotal moment as it adjusts its expectations for fiscal year 2025 following disappointing financial results for the second…
Bruker Adjusts Fiscal Outlook Amid Disappointing Second Quarter Results Bruker Corporation faces a challenging landscape as it announces disappointing financial results for the second quarter of the f…
Bruker Corporation Prepares for Key Earnings Announcement Amid Market Dynamics Bruker Corporation is on the verge of announcing its quarterly earnings on August 4, 2025, a significant event that promi…
Bruker Faces Challenges Amidst Disappointing Guidance Bruker Corporation, a leader in scientific instruments and analytical solutions, faces significant hurdles following its recent second-quarter gui…
Bruker Corporation: Navigating a Complex Market Landscape Bruker Corporation, a leader in scientific instrumentation and analytical solutions, faces a nuanced market environment as recent evaluations…
Bruker's Strategic Settlement with 10x Genomics: A Focus on Intellectual Property in Spatial Biology Bruker Corporation recently finalizes a significant settlement agreement with 10x Genomics, Inc., e…
Bruker and 10x Genomics Settle Patent Disputes, Paving the Way for Collaboration in Spatial Biology In a significant development within the realm of single-cell and spatial biology, Bruker Corporation…
Federal Funding Cuts Raise Concerns for Life Science Tools Sector In a significant policy shift, the Trump administration plans to enforce a cap on indirect costs for the National Institutes of Health…
Bruker's Strategic Acquisitions Propel Growth in Life Sciences and Diagnostics Bruker Corporation, a leader in scientific instrumentation, experiences a significant transformation through strategic ac…